ID: ALA4565282

Max Phase: Preclinical

Molecular Formula: C10H11ClO3

Molecular Weight: 214.65

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(OC(C)C(=O)O)c(Cl)c1

Standard InChI:  InChI=1S/C10H11ClO3/c1-6-3-4-9(8(11)5-6)14-7(2)10(12)13/h3-5,7H,1-2H3,(H,12,13)

Standard InChI Key:  BHOMBGXXWAGXBT-UHFFFAOYSA-N

Associated Targets(Human)

GABA-A receptor; alpha-1/beta-3/gamma-2 1565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 214.65Molecular Weight (Monoisotopic): 214.0397AlogP: 2.50#Rotatable Bonds: 3
Polar Surface Area: 46.53Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.45CX Basic pKa: CX LogP: 2.98CX LogD: -0.41
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.84Np Likeness Score: -1.20

References

1. Stadler M, Monticelli S, Seidel T, Luger D, Salzer I, Boehm S, Holzer W, Schwarzer C, Urban E, Khom S, Langer T, Pace V, Hering S..  (2018)  Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABAA) Receptor Modulators.,  62  (1): [PMID:30289721] [10.1021/acs.jmedchem.8b00859]

Source